Drug Discovery V-Forum

21-22 April 2021

12:30 CET

Register Now

World bi in Drug Discovery 2021

VIRTUAL CONFERENCE

With a 7+ year history of bringing together the global research community to tackle the challenges that the discovery scientists face, World BI prides itself on organizing Drug Discovery V-Forum, a fully virtual conference, in April 2021. Delivering 2 days of top-level strategic content and the current scientific insights, networking, and discussion from leading global pharmaceuticals.
Join 150+ attendees to explore the latest trends & strategies within Discovery Research. This fully online event will be a mixture of on-demand and live sessions so you can join the best in class scientific discussions from the comfort of your home office. This year’s conference will highlight the challenges discovery pipelines have faced due to COVID-19 and put a spotlight on the adoption of technology to combat these.

Here’s a Look at What’s in Store for 2021!

The All-New Agenda

Novel Drug Target Discovery & Validation

⯌ State-of-the-Art Chemoproteomic Technologies

⯌ Advancements in Genome Editing

Enquire

Advances in Medical Chemistry

⯌ The Medical Chemistry in the Era of Machines and Automation

⯌ The Evolving Role of Machine Learning and AI in Computational Chemistry

Enquire

Advances in Drug Design

⯌ Computer Aided Drug Design Approaches against SARS-CoV-2

⯌ Deep Generative Models for Target-Specific & Selective Drug Design

Enquire

AI in Drug Discovery

⯌ Application of Artificial Intelligence in COVID-19 Drug Repurposing

⯌ AI Driven Drug Discovery Models

Enquire

Lead Generation Strategies

⯌ Hit Triage and Validation Strategies

⯌ Chromatography-Free High-Throughput Mass Spectrometry

Enquire

Biologics Drug Discovery

⯌The Next Generation of Biological Therapeutics – A Systematic Review

⯌ Developing Cyclic Peptides into Therapies

Enquire

Fragment - Based Drug Discovery

⯌ 3D Scaffolds for Fragment-Based Drug Discovery

⯌ Implications of Structural Fluctuations for Fragment-Based Drug Design

Enquire

Preclinical Strategies, Models and Tools in Oncology

⯌ Oncology Treatment in the Era of COVID-19

⯌ Preclinical Collaboration to Improve Oncology Drug Development

Enquire

COVID-19 Spotlight: RNA as a Drug Target

⯌ Current Approaches for the Analysis of SARS-CoV-2 RNA Polymerase as a Potential Drug Target

⯌ Small Molecule-RNA Targeting

Enquire


Get Full Agenda


Featured Speakers


Valery Polyakov

Shruthi Bharadwaj, Ph.D

Strategic and Technical Advisor
Chief Data and AI Office

Novartis
Rene Kubiak

Hideyoshi Fuji

Manager

Astellas Pharma
Domingo-Gargallo-Viola
Rajkumar Ganesan

Director – Antibody Engineering (Bispecifics and CAR-T)

The Janssen Pharmaceutical Companies of Johnson & Johnson
Amrik Basran

Tomi Sawyer

Chief Drug Hunter & President

Maestro Therapeutics
Maria Zimina

Sara Colombetti

Global Head of Oncology Discovery Pharmacology

Roche Innovation Center Zurich
Dr. Patrice Denèfle

Caroline Barelle

Chief Executive Officer and Founder

Elasmogen Ltd
Renfeng Guo, M.D

Florent SAMAIN

Group Leader DNA-Encoded Chemical Library

Philochem
Ranga prasad Sarangarajan

Etienne Donckele

Senior Scientist - Deputy Head of Chemistry

Philochem
Umut Eser

Namshik Han, PhD

Head of Artificial Intelligence

Milner Therapeutics Institute University of Cambridge
Vinodh Kurella

Nicolas Bery

Senior Postdoctoral Scientist

University of Oxford, MRC Weatherall Institute of Molecular Medicine
Shashank Patel

Domingo Gargallo-Viola

CEO, CSO

ABAC Therapeutics S.L.
Jacob Becraft

Philippe Moingeon

Head of Therapeutic Area Immuno-Inflammation.

Servier Pharmaceuticals
Jacob Becraft

Elana Hariton Gazal

Head of Pharmaceutical Research.

Neuroderm
Jacob Becraft

Eyal Greenberg, Ph.D., MBA

Chief Executive Officer.

4C Biomed Services Ltd
Jacob Becraft

Oren Herhskovitz

CEO

Enlivex Therapeutics
Jacob Becraft

Dan D. Aridor

Chairman of the Board

AEBI-Bio
Jacob Becraft

Iddo Weiner

Director, Head of Software

BiomX
Jacob Becraft

Rafael Depetris

Principal Scientist II, Lead of Structure Based Drug Design

Kadmon Holdings, Inc.
Jacob Becraft

Dr Michael-Robin Witt

CEO

Gabather.
Jacob Becraft

Frank von Delft

Professor of Structural Chemical Biology

University of Oxford.
Jacob Becraft

Peter Henstock

Machine Learning & AI Technical Lead: Combine AI, Software Engineering, Statistics & Visualization

Pfizer.
Jacob Becraft

Manuela Mally

Director, Head of Research

GlycoEra AG.
Jacob Becraft

Rebecca Eells, PhD

Director of Biophysics

Reaction Biology.
Jacob Becraft

Teodor Aastrup

Founder and CEO

Attana.
Jacob Becraft

Robert Shorr

CEO

Cornerstone Pharmaceuticals
Jacob Becraft

Idit Eshkar-Oren

Director Non-Clinical Safety

Pi Therapeutics
Linda

Linda A. Lieberman

Principal Scientist

MSD


Speaking Opportunity


Unbiased Learning, Invaluable Networking, and Much More!!

WBI Virtual events will help in engaging decision makers virtually by identifying their requirements and tailoring your services to offer the most relevant and valuable services to them thus boosting engagement.

WBI record everything right from the start of the event, during the event, and even after the events get over. It records everything right from registration, login, the number of audiences interacted, information exchange and so on which makes it easy to track and measure the success of the event.

With senior delegation from top companies all over, you can network with peers from different locations all in one place our online.

WBI Virtual events help in tracking, measuring ROI, and planning data-driven strategies to enhance event performance.

WBI Virtual events will allow real-time personalization and conversions as it allows the attendees to interact directly in real-time through comments or chat rooms. One-on-one interactions develop a sense of trust thus leaving an impact on the audience.

WBI Virtual events are cost efficient way to interact with the target buyers. By the means of this inexpensive business development events, you can engage with the decision makers of high intellectual and business relevance without undergoing tedious traveling schedule.

Event Highlights

Attendees

Thought Leaders

Interactive Panels

Discussion Topics



Case Studies

End Users

V-Exhibitors

V-Networking Hours

Our Expert Interviews

“Dr Rob Burgess”

Chief Business Officer

Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant...

Next Interview

Drug Discovery V-Forum Unique Online Meeting Format

Delegates Will Include VPs, Global Heads, Directors, Managers

  • Bioinformatics
  • Principal Research Scientist
  • Translational Immunology
  • Medical Chemistry
  • Innovation
  • Research
  • R&D Senior Scientist
  • Preclinical Development
  • Computational Chemist
  • CSO
  • Data Scientist
  • Non-Clinical Development
  • Biology
  • Early Development
  • Non-Clinical Biostatistics
  • Intelligent Systems Laboratory
  • Chief Scientific Officer
  • Pharmaceutical Research
  • Discovery R&D
  • Senior Scientist
  • CTO
  • Analytical Sciences
  • Machine Learning Research
  • Translational oncology


  • Get Attendee List


    Sponsors

    Media Partners


    Card image cap
    Card image cap
    Card image cap
    Card image cap

    Send Query

    Say hello

    Get in touch

    Call us now

    +442031 29822 2



    Signup Now!

    Our Services!


    Signup Now